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Abstract: Background and Objectives: Overuse and inappropriate use of testing and hospital admission
are common in syncope evaluation and management. Though guidelines are available to optimize
syncope care, research indicates that current clinical guidelines have not significantly impacted
resource utilization surrounding emergency department (ED) evaluation of syncope. Matching
implementation strategies to barriers and facilitators and tailoring strategies to local context hold
significant promise for a successful implementation of clinical practice guidelines (CPG). Our team
applied implementation science principles to develop a stakeholder-based implementation strategy.
Methods and Materials: We partnered with patients, family caregivers, frontline clinicians and staff,
and health system administrators at four health systems to conduct quantitative surveys and qualita-
tive interviews for context assessment. The identification of implementation strategies was done by
applying the CFIR-ERIC Implementation Strategy Matching Tool and soliciting stakeholders’ inputs.
We then co-designed with patients and frontline teams, and developed and tested specific strategies.
Results: A total of 114 clinicians completed surveys and 32 clinicians and stakeholders participated in
interviews. Results from the surveys and interviews indicated low awareness of syncope guidelines,
communication challenges with patients, lack of CPG protocol integration into ED workflows, and
organizational process to change as major barriers to CPG implementation. Thirty-one patients and
their family caregivers participated in interviews and expressed their expectations: clarity regarding
their diagnosis, context surrounding care plan and diagnostic testing, and a desire to feel cared about.
Identifying change methods to address the clinician barriers and patients and family caregivers
expectations informed development of the multilevel, multicomponent implementation strategy,
MISSION, which includes patient educational materials, mentored implementation, academic detail-
ing, Syncope Optimal Care Pathway and a corresponding mobile app, and Lean quality improvement
methods. The pilot of MISSION demonstrated feasibility, acceptability and initial success on appro-
priate testing. Conclusions: Effective multifaceted implementation strategies that target individuals,
teams, and healthcare systems can be employed to plan successful implementation and promote
adherence to syncope CPGs.
Keywords: syncope; emergency department; diagnosis; risk stratification
1. Introduction
Syncope is a common yet complex presenting symptom and requires thoughtful
and efficient evaluation to determine its etiology. Estimates indicate that one-half of all
Americans will experience loss of consciousness during their lives, with recurrence rates
as high as 13.5% [1]. The incidence of syncope is roughly bimodal, with a peak in late
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adolescence to early adulthood, typically vasovagal in origin [2], and a second peak in
older age, with a sharp rise after age 70 years [3]. Approximately 1% to 3% of all emergency
department (ED) visits, as many as atrial fibrillation, and up to 6% of all hospital admissions
are due to syncope [1,4,5]. Though vasovagal reflex-mediated syncope and orthostatic
hypotension are the two most common types with benign courses [6], a cardiac etiology of
syncope is associated with significantly higher rates of morbidity and mortality [3].
Patients who present to the ED tend to be older and are more likely to have a cardiac
etiology [7]. Notably, experiencing syncope affects patients’ quality of life (QoL), and
those with more frequent syncope report overall lower physical and mental health and
impairment in activities of daily living [8–13]. The QoL among patients with recurrent
syncope appears equivalent to those with severe rheumatoid arthritis or chronic lower
back pain [10]. Recurrent syncope can also lead to long-term facility stay and a devastating
loss of independence [14]. In addition to the negative effects on QoL, syncope also has
an economic impact. The U.S. Healthcare Utilization Project has estimated total annual
hospital costs of greater than $4.1 billion in 2014 dollars with a mean cost of $9400 per
admission [15]. One 2017 article showed that, after adjusting for inflation, the median
hospital charge for a single admission for syncope increased by 1.5 times from the preceding
decade [16].
Due to concerns that patients presenting with syncope are at risk for an impending
catastrophic event, overuse and inappropriate use of testing and hospital admission are
common [17–20]. Indisputably, among patients who present with syncope, clinicians must
identify those at high risk of adverse outcomes. Nonetheless, the majority are at low risk.
To assist clinicians in assessing patient risk, several syncope risk stratification calculators
have been developed over the last 20 years; however, one study found that the concordance
between different risk scores was only moderate and the application of both decision rules
and clinical judgement may lead to some clinical benefit [21]. A body of literature docu-
ments under-utilization of efficient tests, over-utilization of unnecessary tests, excess rates
of admissions with limited diagnostic or therapeutic yield, over-expenditure associated
with syncope management, and heightened risk to patients due to unnecessary tests and
hospitalizations, including iatrogenic harms such as medication errors and in-hospital
delirium [17–19,22]. Given the frequency of syncope as a symptom, the cumulative cost
and burden to the healthcare system and patients is substantial.
Aiming to provide guidance on optimizing the evaluation and management of syn-
cope, a collaboration of the American College of Emergency Physicians, Society for Aca-
demic Emergency Medicine, American College of Cardiology (ACC), American Heart
Association (AHA) and Heart Rhythm Society (HRS) issued a Guideline for the Evaluation
and Management of Patients With Syncope in 2017 [15]. The 2017 Syncope Guideline repre-
sents an effort to standardize clinical practice and reduce unnecessary services. However,
the mere existence of a guideline does not guarantee effective use. Evidence shows that the
development of clinical guidelines alone is often not sufficient, even if recommendations in
the guideline have been demonstrated to be effective on the structure, process and/or out-
comes of patient care [23–27]. Indeed, one recent study suggested that the current clinical
guidelines have not significantly impacted resource utilization surrounding ED evaluation
of syncope, and novel strategies are keenly needed to change ED practice patterns for such
patients [28]. Matching implementation strategies to barriers and facilitators for the use
of the syncope guideline and tailoring strategies to local context hold significant promise
for a successful implementation [29–31]. However, evidence on effective implementation
strategies for syncope care in the ED is scarce. Project MISSION, leveraging an engaged
interdisciplinary team, aimed to facilitate the efficient and systematic implementation of
high-value care to patients presenting to an ED with syncope. Our study team applied
implementation science to develop and test a stakeholder-based implementation strategy,
MISSION (Multicomponent, Multilevel Implementation Strategy for Syncope Optimal
Care Through Engagement).
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2. Materials and Methods
2.1. Study Setting and Participants
To maximize the probability that the implementation strategy will be valuable for
widespread adoption and scale-up in different ED settings, Project MISSION included
a diverse group of health systems and hospitals: an academic medical center (AMC);
an urban faith-based community health system; a not-for-profit health system serving a
predominantly rural Appalachian population; and a community teaching hospital in a
suburb. At each facility, the target participants included emergency medicine (EM), hospital
medicine (HM), and cardiology clinicians and stakeholders (e.g., primary care provider,
nurse manager, diagnostic test/procedure manager). Patients and family caregivers were
recruited for interview from the AMC.
2.2. Study Framework
The Consolidated Framework of Implementation Research (CFIR) [32] is commonly
used to guide the design, implementation and evaluation of strategies. CFIR was deemed
to meet the needs of our project, as a determinant framework that can be used to identify
determinants (i.e., barriers and facilitators) thought to affect the likelihood of a clinical
guideline being translated into routine care and influence the implementation process at
different levels (from the user to the program provider, to the organizational level) [33]. In
Figure 1, we delineate the possible influencing factors for syncope clinical practice guideline
(CPG) adoption and implementation through multi-stakeholder effort. The effectiveness of
a multicomponent, multilevel implementation strategy will be mediated by the fidelity with
which the intervention is delivered, and patient outcomes will be moderated by several
patient-level factors. The entire process occurs within a context composed of system-level,
organizational-level, and provider-level factors known to influence the implementation of
a CPG [34].
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Figure 1. Project MISSION Guiding Framework, adapted from CFIR [32].
2.3 Development of Implementa ion Strategy (MIS ION)
Table 1 delineat s the influencing factors f syncope CPG adoption and implementa-
tion and lists the activi ies performed to assess determinants. The study team partner d
with pati nts, family caregivers, frontline clinicians and staff, and a ministrators to as-
sess contextual fa tors (e.g., patient preferences and needs, clinician per eptions, local
orga izational structure, ope ating philosophy and culture) and readiness for sy cope
guidelin impl mentation. We conducted focus groups and interviews of patients and
their family caregivers, clinicians and staff, and administrators [35,36]. We also surveyed
clinicians and staff to understand unique challenges and barriers in each of these systems.
The implementation questions addressed: (1) what are the facilitators/barriers to deliver-
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ing guideline-based evaluation and management of syncope within the local context, (2)
how likely will the recommendations be delivered as prescribed (fidelity), and (3) what
strategies might maximize the facilitators and overcome barriers to implementation? After
completing context assessments, identifying barriers and facilitators, and soliciting stake-
holders’ inputs on strategies, we used the CFIR-ERIC (the Expert Recommendations for
Implementing Change compilation) Implementation Strategy Matching Tool [37] to help
select and tailor MISSION components to mitigate barriers and leverage facilitators.




1. Survey—Organizational Readiness to Change
Assessment (ORCA)
2. Focus groups and key informant
interviews—clinicians and stakeholders
Structural characteristics (e.g., availability
of electronic information infrastructure)
Focus groups and key informant
interviews—clinicians and stakeholders
Individual Characteristics
Patient needs, values, and preferences Focus groups—patients and family caregivers
Provider attitudes to evidence-based
practices
Survey—revised Evidence-Based Practice Attitudes
Scale (EBPAS-36)
Intervention Characteristics Strength of evidence, relative advantage,adaptability, and complexity
Focus groups and key informant
interviews—clinicians and stakeholders
2.4. Analysis
Descriptive statistics were calculated for each survey item. Bivariate analyses were
used to assess associations between characteristics (clinician specialty, hospital setting)
and attitudes and readiness among respondents. Data were analyzed using SAS 9.4 (SAS
Institute, Cary, NC, USA).
The interviews were transcribed verbatim for content analysis. The study team de-
veloped initial code books based on their clinical and implementation expertise. Coding
took place in two stages. During the first stage, two research staff coders independently
reviewed the transcripts to identify unique themes using NVivo 12 software (QSR Interna-
tional, Melbourne, Australia). After the first round of coding, both coders met to discuss
any disagreements and refine the schema of codes and to refine the codebook for additional
rounds of coding. Then, two coders met with the study team’s qualitative expert to discuss
and refine the coding schema by merging, reformulating, or rephrasing codes to more
accurately fit the data and create one cohesive codebook. The two original coders then
co-coded each transcript. Analytical memos were created and discussed as a group over a
series of weekly meetings with the goal of refining and finalizing themes and categories.
This study was approved by the University of Kentucky Institutional Review Board
(protocol #45255).
3. Results
3.1. Clinician Survey and Interview
Project MISSION achieved broad engagement across multiple practice settings. One
hundred fourteen clinicians completed surveys and thirty-two clinicians and stakeholders
participated in interviews [22,35]. The survey and interview results have been reported
in detail elsewhere [22,35]. Briefly, among clinicians, awareness and implementation of
the 2017 Syncope Guideline was low. We identified practice gaps in under-reporting of
orthostatic vital signs and overuse of cardiac and neurologic imaging, as well as barriers
to adoption and implementation of evidence-based care across multiple levels. Survey
results revealed that overall attitude toward evidence-based practices was moderate, and
implementation of new guidelines were seen as a burden, potentially decreasing the
likelihood of compliance. Of the multiple patient, provider, and organization-related
Medicina 2021, 57, 570 5 of 11
barriers to syncope guideline implementation, we identified communication challenges
with patients, lack of CPG protocol integration into ED workflows, and organizational
process to change as major barriers to implement CPGs in syncope care [35].
3.2. Patient and Family Caregiver Focus Group
Project MISSION focus group sessions were conducted to understand patient needs,
values and preferences. A total of 31 patients and their family caregivers, 23 patients
and 8 caregivers, participated in interviews [36]. They described their expectations when
presenting to the ED with syncope including: (1) clarity regarding their diagnosis or cause
of their syncope, (2) context surrounding care plan and care teams’ approach to diagnostic
testing, and (3) desire to feel seen, heard and cared about by the healthcare team.
3.3. Implementation Barrier—Strategy Mapping
The findings from quantitative surveys and qualitative interviews helped guide
decisions about the types of strategies that may be appropriate and match the needs
of the local context. Based on the CFIR-ERIC Implementation Strategy Matching Tool
(www.cfirguide.org (accessed on 20 March 2021)), we elicited input from the study team,
frontline clinicians and staff, and administrators on choosing which ERIC strategies would
best address specific CFIR-based barriers in guideline recommended syncope evaluation
and management. Table 2 lists the identified CFIR barriers and ERIC recommended strategies.
Table 2. Syncope Clinical Practice Guideline (CPG) implementation barriers and recommended strategies.
Identified CFIR Barriers ERIC-Endorsed, MISSION Stakeholder-Recommended Strategies
Intervention—Complexity • Promote adaptability
• Develop an implementation toolkit
• Conduct cyclical small tests of change
• Conduct ongoing training
Clinicians and stakeholders believe that the syncope
CPG is complex based on their perception of duration,
scope, disruptiveness, and number of steps needed to
implement.
Outer Setting—Patient Needs • Prepare patients to be active participants
• Involve patients and family caregivers
• Equip clinicians with tools to help communication
Clinicians feel the pressure to satisfy patients (i.e.,
consumerism).
Patient needs are not known or fully understood by
clinicians.
Inner Setting—Culture and Learning Climate • Facilitation by external agent/adviser
• Identify and prepare champions
• Identify and prepare core implementation team
• Recruit, designate and train for leadership
• Conduct local consensus discussions
• Organize clinician implementation team meetings
Cultural norms and basic assumptions hinder
implementation.
Clinicians do not feel that they are essential, valued, and
knowledgeable partners in the implementation process.
Clinicians do not feel psychologically safe to implement
guidelines.
Inner Setting—Compatibility • Conduct local consensus discussions
• Promote adaptability
• Tailor strategies
• Lean QI methods
The syncope CPG recommendations do not fit well with
existing workflows, nor align well with clinicians’ own
needs.
Individuals—Knowledge & Beliefs about the Intervention • Conduct educational meetings
• Develop educational materials
• Conduct educational outreach visits
• Identify and prepare champions
• Inform local opinion leaders
Clinicians are not familiar with 2017 Syncope Guideline.
Some clinicians have negative attitudes toward
guidelines and place low value on implementing them.
Individuals—Self-efficacy • Identify and prepare champions
• Provide ongoing consultation
• Conduct ongoing training
• Make training dynamic
Clinicians and stakeholders do not have confidence in
their capabilities to execute courses of action to
achieve implementation goals.
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3.4. MISSION Implementation Strategy Components
After assessing and understanding determinants within the local context and identify-
ing change methods to address those determinants, the last step was to develop strategy
components to address the determinants considering how barriers interact with syncope
care-specific needs. This process was also complemented with Fernandez and colleagues’
five-step Implementation Process [38] and iterative feedback from stakeholders to further
operationalize these components. Table 3 shows the multicomponent, multilevel implemen-
tation strategy (i.e., MISSION) components and expected functions/outcomes achieved.
Table 3. MISSION components.
MISSION Components Expected Functions/Outcomes
Patient educational materials • Prepare patients and family caregivers
• Assist clinician with challenging communicationsVideo: Setting Expectations; What’s Next?
Syncope Types: one-page document facilitating
clinician-patient communication
External implementation mentor • Create or Enhance culture of learning health systems and
continuous improvement
• Enhanced leadership engagement in and endorsement of
CPG implementation in syncope care
• Enhanced self-efficacy of local implementation team
• Knowledge and skill transfer to local team and local
implementation capacity building
Pre-implementation planning visit
Series of ten monthly virtual meetings with local
implementation team, including champion, implementation
leader and opinion leaders
Mid-implementation visit
Technical assistance with Lean QI methods
Academic detailing • Clinician attitude and behavior changes
• Adherence to syncope CPGs and improvements in patient
outcomes
Direct educational outreach to local clinicians
Clinical vignettes
Discussion with clinicians in their practice setting
Syncope Optimal Care Protocol
• Frontline-endorsed protocol as institutional policy
• Enhanced clinician receptivity to standardized clinical
pathway with flexibility
Syncope MISSION App [39] (iOS and Android)
• Operationalized Syncope Optimal Care Protocol
• Enhanced clinical decision support
Lean QI methods
• Redesigned/optimized care process/workflow at ED with
syncope CPGs integrated
Syncope MISSION Implementation Tool • Operationalized implementation processes
Syncope patients see testing as a means to achieve clarity on their otherwise ambigu-
ous condition. Clinicians can focus on two-way communication by engaging in active
listening, obtaining a complete patient history, and explaining the rationale for or against
various testing options. Printed educational materials are one of the most common forms
of communicating guidelines. Our team developed educational videos (intake and dis-
charge videos) to help align patient expectations regarding testing to fit with guideline
recommendations, as well as tailored patient educational materials to better explain their
specific syncope diagnosis. The Hospital Patient Education Department and the Patient
and Family Advisory Group reviewed all educational materials, providing feedback and
editing the materials to ensure an appropriate reading level. Additionally, we created a
discharge document incorporating principles of adult learning theory and health literacy
to help providers educate patients on the details of their diagnosis, preventive measures,
and instructions to follow at the time of discharge.
In addition to clinical decision support (CDS) tools, the strategies aiming to promote
clinician behavior change and optimize clinical process include mentored implementation
combined with academic detailing. Mentored implementation provides external expert
facilitation to enable and support health systems to make and sustain change, and efficiently
integrate efforts into current workflow. It also facilitates active stakeholder engagement,
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offers ongoing support, and equips local champions for sustainability. This approach
is proven to enhance adoption and implementation of evidence-based programs and
innovations [40,41]. Academic detailing [42–44] is peer-to-peer educational outreach and
addresses situations where there is an opportunity to change clinician behavior with
focused and practical educational content. It can also help build leadership’s buy-in to
the proposed practice changes and help them understand how they can help the frontline
implement these changes.
Project MISSION also created implementation strategies that address the process of
integrating essential content from syncope CPGs to the local practice context and work-
flow. Clinical protocols provide specific guidance for management of groups of patients,
in an algorithmic structure that facilitates clinical decision-making, tailored to the local
environment. With input from diverse health systems and engagement of interdisciplinary
expertise, our study team developed the Syncope Optimal Care Protocol based on the 2017
Guideline. The Syncope Optimal Care Protocol provides a standardized clinical pathway
that has flexibility to make it more attractive to clinicians and aids in reducing variability,
while improving quality and lowering cost. Next, a MISSION mobile application (App)
was designed to be a practical tool for the implementation of the Syncope Optimal Care
Protocol and serve as a CDS tool for syncope diagnosis and prognosis that walks users
through clinical assessment in a clear and concise manner, and provides recommendations
based on input from the user [39].
Finally, to address workflow compatibility and care process redesign, Lean quality
improvement (QI) [45] tools were selected to be part of the implementation strategies.
Lean generally focuses on how a process is currently operating and what opportunities
exist to improve the process in a local setting, and therefore is a best practice in tailoring
implementation. Application of Lean QI methods and tools aims to increase the likelihood
of sustaining the daily practice and maximizing its impact in each health system.
3.5. MISSION Implementation Strategy Pilot
The Project MISSION implementation strategy was piloted from 17 Feb through 13
March 2020 at an AMC ED. The pilot stopped earlier than scheduled due to COVID-19,
but demonstrated feasibility and acceptability, with 91.7% (22/24) of approached patients
watching education videos with voiced approval, and 34 clinicians downloading and using
the MISSION App. The 2017 Syncope Guidelines recommends that orthostatic vital signs,
a low-cost, effective diagnostic test, are included as a required part of the physical exami-
nation for patients presenting with syncope. However, according to recent literature [46]
and data reported by hospitals in this study, orthostatic vitals were underused, being per-
formed on only 15% to 40% of patients. Routine head CT scan without a severe coexisting
injury or disease is not recommended in the 2017 Syncope Guideline. A 2019 systematic
review showed that more than half of patients with syncope underwent head CT scan
at ED, but with a diagnostic yield of only 1.1% to 3.8% [47]. Based on the literature and
stakeholders’ recommendations, orthostatic vital signs and head CT orders are two major
implementation outcome measures in our study. Given the low baseline, a relative 50%
increase in orthostatic vital signs will be considered as clinically significant, and given the
high baseline, a relative 20% reduction in head CT scan orders will be clinically significant.
Following MISSION implementation, we found that orthostatic vital sign measurement
increased from 29% to 43% (χ2 statistic = 4.2664, p-value = 0.0389) and inappropriate head
CT orders reduced from 48% to 37% (χ2 statistic = 2.3641, p-value = 0.1242). This demon-
strated a clinically significant improvement in implementing CPGs in the evaluation and
management of syncope.
4. Discussion
4.1. Evaluation of Barriers Is a Necessity in Planning CPGs Implementation
Despite substantial efforts by medical researchers and professional societies [15,48,49],
overuse and inappropriate use of testing and hospital admission are common in patients
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presenting with syncope. The most efficient solution to improve patient outcomes is most
likely to adopt standardized criteria for evaluation and treatment administration based on
the recommendations contained in guidelines. However, the uneven implementation of
evidence-based CPGs is widely recognized as a continuing challenge to improving health-
care delivery and public health [50,51]. Implementation science provides an empirical base
for promoting adoption of CPGs and its research is dedicated to accelerating the pace of
implementing evidence-based interventions in real-world healthcare settings. What deter-
mines the rate and extent of adoption is the interaction among characteristics of the CPG,
the intended users, and a particular context of care setting. As part of the clinical guideline
implementation planning process, a more detailed evaluation of underlying barriers and
facilitators and how these determinants can be addressed by strategies is needed.
4.2. Local Context Tailored Implementation Strategy Is Essential
While tailoring to local context seems intuitive, most studies have not tailored imple-
mentation strategies to context. Healthcare delivery settings influence every step of how
care is given, yet far more work is needed to effectively describe and link these structural
and process characteristics to outcomes and to develop setting-changing interventions
to improve care. Numerous conceptual frameworks (e.g., CFIR) have been developed
to guide the identification and systematically assess potential determinants within local
settings. Project MISSION was the first effort that specifically applied IS principles and
methods to develop strategies and plan implementation processes to overcome multilevel
barriers to deliver guideline-recommended, high-value care to patients presenting with
syncope in the ED. It integrated behavioral interventions and healthcare process redesign,
used stakeholder-engaged and local-context congruent approaches, and fostered a learning
health system approach spanning an academic medical center and community hospitals.
Development of MISSION ensured tailoring of implementation strategies in the local set-
ting to accommodate variations and to sustain improved syncope care through tailored
implementation. For example, patient educational videos can be edited by inserting a
tailored intro and outro delivered by a recognizable, local clinician to enhance patient
buy-in. In addition, the video can be presented in various ways based on each system’s
infrastructure: via its system-wide patient education platform (either standalone or part
of electronic health record-EHR), through a QR code to play on patients’ smartphones, or
through an iPad in patient rooms. Another example, supported by an external implemen-
tation mentor, is that the local implementation team can use local detailed process maps to
systematically identify process steps with opportunities, and test and refine strategies to
increase guideline-recommended syncope care delivery through iterative test cycles.
Limitations to the project should be mentioned. While the organizational structure,
hospital characteristics, and patient populations are diverse, the themes presented in this
paper were generated based on the responses of participants located in the same state.
Second, pilot data were limited due to COVID-19 research restrictions. A larger pilot and
implementation will be launched in our state, as well as others, once hospitals move into
post-pandemic operation.
Identifying a barrier is not sufficient to guide the choice of an implementation strat-
egy. The causes of each barrier must be specified along with the desired outcome, and
the specific methods or techniques must be identified and operationalized into concrete
strategies to influence these determinants. A process akin to systematically identifying
barriers, change methods for addressing them, and development or selection for specific
strategies is essential in implementing CPGs. Unfortunately, this approach is not typically
followed, leading to gaps in understanding which strategies work and why they produce
their effects. Project MISSION represents an example that utilized CFIR to characterize
contextual determinants of CPG use, analyzed those determinants systematically via a
theoretical framework, identified specific behavior change targets, and then selected rel-
evant implementation strategies. Pilot testing of MISSION demonstrated feasibility and
acceptability among patients, frontline clinicians and staff, and administrators. Our next
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step is to determine whether MISSION is an effective, generalizable strategy in a pragmatic
clinical trial across multiple health systems.
5. Conclusions
Effective multifaceted implementation strategies targeting individuals, teams, and
healthcare systems should be employed to plan successful implementation and promote
adherence to CPGs. MISSION, developed by following implementation science principles,
can optimize syncope care and translate CPGs into widespread clinical practice.
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